Cannabis Giant Tilray Expands Medical Marijuana Portfolio With Redecan Launch In Australia - Tilray Brands ( NASDAQ:TLRY )
Tilray Medical, a division of Tilray Brands, Inc. TLRY TLRY announced on Wednesday the launch of Redecan EU-GMP certified medical cannabis products in Australia. What Happened: The following Redecan products are now available for medical cannabis patients in Australia, including:
| Ticker |
Sentiment |
Impact |
|
TLRY
|
Somewhat Bullish
|
54 %
|
|
TSOI
|
Neutral
|
15 %
|
